Company intelligence / Profile preview
Virpax Pharmaceuticals
Berwyn, Pennsylvania, USA
- Ownership
- Public · VRPX
- Development stage
- Preclinical
01
Overview
Virpax Pharmaceuticals develops non-addictive therapeutics for severe pain, CNS disorders, and viral infections using advanced drug delivery platforms. Lead program Probudur has shown promising preclinical results with extended post-surgical analgesia and reduced opioid need. Envelta demonstrated analgesic potential without tolerance or reward-seeking behavior in animal models. NobrXiol leverages MET for intranasal CBD delivery targeting rare pediatric epilepsy with FDA PIND guidance received. AnQlar showed strong antiviral activity against influenza/COVID in preclinical studies.
- Therapeutic areas
- NeurologyInfectious DiseasesRheumatology
- Modalities
- Small molecules (e.g., bupivacaine)Peptides (enkephalin analogs)Cannabinoids (CBD)Nanoparticle/liposomal formulations
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Partnerships
National Institutes of Health/National Center for Advancing Translational Sciences—CRADA on EnveltaDepartment of Defense—CRADA on select candidatesNanomerics Ltd.—technology licensing partner for MET platform
04
Financials
- Market cap
- $124
- Total revenue
- $0
- Enterprise value
- $-1.5M
Beyond the preview
Go deeper on Virpax Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virpax Pharmaceuticals.